BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 18802361)

  • 1. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
    Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
    Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
    Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
    J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study on cluster and conventional immunotherapy with Dermatophagoides pteronyssinus in patients with allergic rhinitis].
    Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):981-5. PubMed ID: 22336008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
    Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
    J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
    Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The results of specific immunotherapy for house dust mites in patients with allergic rhinitis].
    Sahin E; Taş E; Dağtekin Ergür EN; Cuhali BD; Gürsel AO
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(2):79-84. PubMed ID: 18628641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
    Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
    Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
    Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy.
    Tabar AI; Muro MD; García BE; Alvarez MJ; Acero S; Rico P; Olaguíbel JM
    J Investig Allergol Clin Immunol; 1999; 9(3):155-64. PubMed ID: 10412677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous intradermal low-dose house dust mite immunotherapy in tropical settings: a valid cost-effective approach for developing nations?
    Rondon C; Sánchez-Borges M; Cupello ER; Fabiano F; Capriles-Hulett A
    Allergol Immunopathol (Madr); 2021; 49(2):31-39. PubMed ID: 33641291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy and immunological changes in children with allergic rhinitis receiving specific immunotherapy with Dermatophagoides pteronyssinus].
    Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Wang Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 46(1):36-9. PubMed ID: 21429334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term efficacy of Dermatophagoides pteronyssinus immunotherapy in patients with allergic rhinitis: a 3-year prospective study].
    Wang CS; Wang XD; Zhang W; She WY; Xi L; Ouyang YH; Zhao Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):804-8. PubMed ID: 23302159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.